Case of Chemotherapy-Refractory,
RAS
-Mutated Chronic Myelomonocytic Leukemia Responsive to Single-Agent Trametinib Based on Results From a High-Throughput Drug Screen
JCO Precis Oncol
.
2020 Nov:4:1367-1373.
doi: 10.1200/PO.20.00270.
Authors
Anna B Halpern
1
2
,
Timothy J Martins
3
,
Erica C Jonlin
3
,
Jin Dai
1
,
Sylvia Chien
1
,
Pamela S Becker
1
2
3
4
Affiliations
1
Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.
2
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA.
3
Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
4
Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA.
PMID:
35050791
DOI:
10.1200/PO.20.00270
No abstract available